One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Orthotopic and metastatic tumour models in preclinical cancer research
Stephen M. Stribbling a,�, Callum Beach b , Anderson J. Ryan
doi : 10.1016/j.pharmthera.2024.108631
Volume 257, May 2024, 108631
Immunotherapy for depression: Recent insights and future targets
Ying Bai a,�,1 , Yang Cai a,1 , Di Chang b , Daxing Li a , Xinchen Huo a , Tianhao Zhu a
doi : 10.1016/j.pharmthera.2024.108624
Volume 257, May 2024, 108624
Efficacy and safety of transarterial chemoembolization combined with lenvatinib and PD-1 inhibitor in the treatment of advanced hepatocellular carcinoma: A meta-analysis
Lei Wang a , Li Lin b , Wei Zhou
doi : 10.1016/j.pharmthera.2024.108634
Volume 257, May 2024, 108634
Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentials
doi : 10.1016/j.pharmthera.2024.108635
Volume 257, May 2024, 108635
Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment
Magdalena Strachowska a,b,1 , Agnieszka Robaszkiewicz
doi : 10.1016/j.pharmthera.2024.108636
Volume 257, May 2024, 108636
Epigenetic determinants and non-myocardial signaling pathways contributing to heart growth and regeneration
Jihyun Jang a,b,��, Federica Accornero c , Deqiang Li
doi : 10.1016/j.pharmthera.2024.108638
Volume 257, May 2024, 108638
SIRT3: A potential therapeutic target for liver fibrosis
Yan Ning a,1 , Xinyue Dou a,1 , Zhichao Wang a , Kao Shi a , Zeping Wang a , Chuan Ding a , Xianan Sang a , Xiang Zhong a , Meiyu Shao a , Xin Han a,�, Gang Cao
doi : 10.1016/j.pharmthera.2024.108639
Volume 257, May 2024, 108639
